Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Solution provides integrated capabilities to enhance data-sharing for supply chain protection
September 27, 2017
By: Tim Wright
Editor-in-Chief, Contract Pharma
UPS has introduced a new technology to help healthcare companies better synchronize and share information for serialized pharmaceuticals in the U.S. supply chain as required by the Drug Supply Chain Security Act (DSCSA), passed in 2013. The law requires implementation, over a 10-year period, of serialization, enhanced traceability, and data reporting to help secure the drug supply chain and increase consumer safety. Under the law, U.S. drug manufacturers and life science organizations must build the capability to produce and communicate a standardized, unique numerical identifier for each package or homogenous case for each sellable unit of prescription drugs. Key goals are to verify, document and authenticate every drug product transaction along the supply chain from manufacturer to wholesaler to pharmacy or health care provider. “The DSCSA is a complex yet important law to standardize the patch work of various state laws so that all supply chain stakeholders are better equipped to help secure the pharmaceutical supply chain. It will also allow for better performance of existing supply chain processes such as managing recalls,” said Tim Bishop, UPS manager of healthcare compliance. “Our system is a smart conduit on information-sharing and data flow that will help secure the drug supply chain and trace the movement of pharmaceuticals.” The DSCSA has a far-reaching impact on manufacturers, drug distributors, repackagers, wholesale distributors, dispensers and logistics providers. Under the DSCSA, after Nov. 27, 2017, wholesalers are no longer allowed to accept drug packages without a serial number. Although the FDA recently published draft guidance indicating it would use enforcement discretion for this requirement until November 2018, the requirement is in place and the expectation is for the industry to be ready to comply. By 2019, wholesalers may only accept returned product for redistribution if the product can be associated with corresponding track-and-trace documents and if it can verify the product identifier. By 2023, all systems must be in place to track individual drug packages back to the original manufacturer or repackager. UPS’s solution is designed to help enable critical functions including, but not limited to: verification and authentication of serial numbers, data repository to meet the six-year data retention requirement, scanning and identification of bar codes and management of levels of aggregation, and tracing individual packages back to original cartons and pallets. UPS can deploy this core system globally using its warehouse management system. “Stakeholders across the board will have streamlined, standardized visibility into pharmaceutical shipments. When a customer makes an inquiry, we can tell when the shipment came in, when packages went out, what serial numbers made up that order, and more,” said David Quintilio, UPS vice president of global healthcare logistics and distribution. “We wanted an interoperable solution that could be used globally and modified to meet regional compliance requirements. Of course, it also had to facilitate the exchange of information efficiently.” UPS has been involved in a number of industry coalitions to help standardize U.S. and global guidelines for supply chains. UPS also works to impact global policies so healthcare manufacturers and their logistics partners can effectively evaluate and respond to new rules. “When we work collaboratively across borders, together we can harmonize compliance mandates more efficiently and help to better protect the international supply chain,” said Mr. Bishop.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !